Completed NA INTERVENTIONAL 2-arm NCT01324401

Oral Peanut Immunotherapy (PNOIT)

Sponsor: Massachusetts General Hospital

Updated 7 times since 2017 Last updated: Jul 11, 2018 Started: Mar 31, 2011 Primary completion: May 31, 2016 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Peanut Allergy and is currently completed. Massachusetts General Hospital leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2018 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2018 — Sep 2018 [monthly]

Active Not Recruiting NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States